Take Another Look at PODD 2011

A Presentation on the Wall Street View on Current and Emerging Opportunities in Drug Delivery Partnerships.

This Presentation was delivered by Ian Sanderson, of Cowen Group during the 2011 PODD program.

Out of the Box Registration Options for PODD 2012!

• Partial and Full Scholarships available for early stage biotechs looking for a drug delivery partner
• Group Discounts for three or more from the same company, 15% Off
• Complimentary passes for biotech, pharma and life science investors attending only the Drug Delivery Technology presentations on October 1st from 2:00pm to 7:00pm

To inquire on any of the above, please email us atService@theconferenceforum.org

Another Peak at PODD 2011

A Presentation on Transforming a New Drug or Technology into a Marketed Product.

This Presentation was delivered by Mark J. Kontny, PhD, of Patheon Inc. during the 2011 PODD program.

Combating Drug Resistance

Drug resistance is a growing problem in modern medicine. The issue of drug resistance encompasses resistance of bacteria, viruses, parasites and other organisms to antibacterial agents and other drug treatments. This article examines the emergence of multidrug resistant pathogens and introduces a few of the methods available to address the issue - including some new developments at the frontiers of modern drug research.

Drugs and Antimicrobial Agents

Naturally available plants and moulds have been used for thousands of years (some more successfully than others) as a treatment for a broad range of ailments. However, it is only over the last couple of centuries that medicine has matured into an important field in modern science, and the use of drugs has led to a marked improvement in hygiene, health and life expectancy.

Since the discovery of penicillin in 1928, the use of antibiotics and other medicinal drugs has become a global industry with a value measured in hundreds of billions of dollars. Indeed, the use of drugs - including antivirals and antimicrobial agents - are central to medicine today. The use of manufactured antibiotics is now widespread both in humans and in livestock. We rely on antibiotics, antivirals, vaccines and other forms of medicine to protect us against sickness and disease. However, there is a problem....

For more on this article from PODD Media Partner, Pharmaceutical Int. Please visit here.

A Peak at PODD 2011

A Presentation on Practical Guidance to Conveying the Value in your Drug Delivery.

This Presentation was delivered by Fernando Salles, PhD, CLP, of Merck & Co. Inc. during the 2011 PODD program.

For the 2012 program agenda, please click here.

Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD

New York, NY — In an effort to remove barriers and embrace collaborations to get therapeutics to patients faster, pharmaceutical and biotech companies will listen to more than 25 drug delivery technology presentations, ranging from novel delivery devices to formulation technologies at the 2nd Annual PODD: Partnership Opportunities in Drug Delivery conference, October 1-2, 2012, at the Boston Park Plaza hotel in Boston, MA.

Keynotes

The PODD program is designed to introduce emerging and enabling drug delivery technologies to help pharmaceutical and biotech drug formulators obtain better clinical outcomes for patients. The PODD event features keynote addresses by two leading scientists in drug delivery, Dr. Robert Langer, the David H. Koch Institute Professor, MIT, and Dr. Stephen Oesterle, Senior Vice President for Medicine and Technology, Medtronic.

Leadership

Dr Barbara Lueckel, Global Business Development Director, Roche returns as the PODD Chairperson. Dr. Lueckel found the inaugural PODD event served as a platform to facilitate innovative collaborations, noting that, “The panels provided an opportunity to gain further insights into companies' thinking on drug delivery partnering and to engage panelists into additional discussions.” She also said, “I am glad we will see more panel discussions in 2012.”

Additional industry experts speaking at PODD include:

· Dr. Sesha Neervannan, Vice President, Pharmaceutical Development, Allergan

· Dr. Julia Rashba-Step, Senior Director, Novel Delivery Technologies, Pfizer

· Dr. Anand Subramony, Head of Novel Delivery Technologies & Therapeutics, Novartis

· Dr. Keith Horspool, Vice President, Pharmaceutical Development, Boehringer Ingelheim

Further highlights of the PODD program include pre-arranged one-on-one partnering meetings, a drug delivery exhibit hall, numerous networking breaks and a reception. Over 250 attendees are anticipated. Companies participating in the 2012 PODD event include Allergan, Aptalis, Becton Dickinson, Boehringer Ingelheim, CIMA Labs, GlaxoSmithKline, Janssen, 3M Drug Delivery Systems, Medtronic, Merck, Novartis, MannKind, Patheon, Pfizer, Roche, Shire, Catalent and many more.

To register, use code BLOG for 10% off and click here.

For more information, please visit www.theconferenceforum.org or call 646-350-2580.

PODD 2011 Pictures

Click here to view these pictures larger

Pictures from our PODD 2011 Event, Omni Parker House Hotel, Boston, MA. For more information on our upcoming 2012 event, click here. Or join our LinkedIN group here.